LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 84.90 7 3254 0.0022 -0.3777
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 84.90 1653 3254 0.5079 0.7584
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 84.90 38 3254 0.0117 -0.1417
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 84.90 1328 3254 0.4081 0.6867
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 84.90 1663 3254 0.5110 0.7604
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 84.90 1705 3254 0.5239 0.7687
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.43 84.90 14 3459 0.0040 -0.2861
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.43 84.90 1732 3459 0.5006 0.7573
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.43 84.90 54 3459 0.0156 -0.0811
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.43 84.90 1364 3459 0.3943 0.6806
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.43 84.90 1739 3459 0.5027 0.7587
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.43 84.90 1779 3459 0.5142 0.7661
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 40.14 84.90 12 3682 0.0033 -0.3022
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 40.14 84.90 1794 3682 0.4872 0.7523
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 40.14 84.90 44 3682 0.0120 -0.1138
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 40.14 84.90 1434 3682 0.3895 0.6816
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 40.14 84.90 1835 3682 0.4984 0.7596
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 40.14 84.90 1859 3682 0.5049 0.7638
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.84 84.90 8 4003 0.0020 -0.3462
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.84 84.90 1880 4003 0.4696 0.7458
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.84 84.90 54 4003 0.0135 -0.0782
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.84 84.90 1495 4003 0.3735 0.6753
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.84 84.90 1922 4003 0.4801 0.7527
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.84 84.90 1954 4003 0.4881 0.7579
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 43.55 84.90 13 4287 0.0030 -0.2822
MN20160318_Q02
H19